Vr Adviser, LLC Glycomimetics Inc Transaction History
Vr Adviser, LLC
- $414 Million
- Q1 2025
A detailed history of Vr Adviser, LLC transactions in Glycomimetics Inc stock. As of the latest transaction made, Vr Adviser, LLC holds 3,000,000 shares of GLYC stock, worth $47.1 Million. This represents 0.15% of its overall portfolio holdings.
Number of Shares
3,000,000
Previous 3,000,000
-0.0%
Holding current value
$47.1 Million
Previous $750,000
16.0%
% of portfolio
0.15%
Previous 0.12%
Shares
1 transactions
Others Institutions Holding GLYC
# of Institutions
28Shares Held
26.8MCall Options Held
80.9KPut Options Held
20.8K-
Bvf Inc San Francisco, CA9.54MShares$150 Million0.09% of portfolio
-
Logos Global Management LP San Francisco, CA5.4MShares$84.8 Million0.22% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA5.09MShares$79.9 Million0.0% of portfolio
-
Wellington Management Group LLP Boston, MA1.37MShares$21.5 Million0.0% of portfolio
-
Black Rock Inc. New York, NY723KShares$11.4 Million0.0% of portfolio
About GLYCOMIMETICS INC
- Ticker GLYC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 52,423,900
- Market Cap $823M
- Description
- GlycoMimetics, Inc., a clinical-stage biotechnology company, focuses on the discovery and development of novel glycomimetic drugs to address unmet medical needs resulting from diseases in the United States. It is developing uproleselan, an E-selectin inhibitor, which is used in combination with chemotherapy to treat acute myeloid leukemia (AML),...